http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004009170-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-34 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-34 |
| filingDate | 2002-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f7e75e8b1c5d9bdc1b845a934eba308 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bcdc3a00b6381e03e44885f424dfbdc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08827c957dffb5c655b2ff5ce49369f7 |
| publicationDate | 2004-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2004009170-A1 |
| titleOfInvention | Alpha-melanocyte stimulating hormone peptides protection in organ transplantation |
| abstract | A composition and method for controlling host response to organ and/or tissue transplantation and grafting. Alpha-Melanocyte Stimulating Hormone protects organ and tissue transplantation by controlling factors within the donor, host and of the organ or tissue to be transplanted. Treatment with α-MSH and/or its derivatives can affect warm and cold ischemia times and thus promotes organ viability. Treatment of the donor, host and of the organ or tissue to be transplanted with an appropriate dosage of α-MSH and/or its derivatives limits biochemical pathways that would normally work to reject an organ and/or tissue transplantation. α-MSH augments successful graft transplantation whether it be allograft or xenograft. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100819838-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004219232-A1 |
| priorityDate | 2002-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 500.